HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/20308564

Proc. Natl. Acad. Sci. U.S.A. 2010 Apr 6 107 14 6532-7

Download in:

View as

General Info

PMID
20308564